Podcasts
Listen to the latest oncology news from international experts
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
Lung Cancer Screening: Current state and future directions
Lung cancer is one of the most common cancers in the world, and has a very low survival rate, partly due to many patients being diagnosed only once their disease has reached an advanced stage. Screening programmes for high-risk populations are a possible solution to this problem, as it would help to identify more lung cancer cases when they are in early stages, and are therefore more treatable.
In this podcast, we explain the current guidelines from the US, UK, and Europe, talk on key trials in lung cancer screening, and hear from leading experts about possible future screening methods.
Date: 1st April 2022
